APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lower Limb Exoskeleton Rehabilitation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lower Limb Exoskeleton Rehabilitation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchLower Limb Exoskeleton Rehabilitation Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Lower Limb Exoskeleton Rehabilitation Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Lower Limb Exoskeleton Rehabilitation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lower Limb Exoskeleton Rehabilitation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lower Limb Exoskeleton Rehabilitation Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lower Limb Exoskeleton Rehabilitation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lower Limb Exoskeleton Rehabilitation include Milebot, Hangzhou Taixi Intelligent Technology, Hangzhou Chengtian Technology, Parker Hannifin, Panasonic, Myomo, Marsi Bionics, LockHeed Martin and Lifeward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lower Limb Exoskeleton Rehabilitation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lower Limb Exoskeleton Rehabilitation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lower Limb Exoskeleton Rehabilitation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lower Limb Exoskeleton Rehabilitation market size, projected growth trends, production technologies, key applications, and end-use industries.

Lower Limb Exoskeleton Rehabilitation Segment by Company

Milebot

Hangzhou Taixi Intelligent Technology

Hangzhou Chengtian Technology

Parker Hannifin

Panasonic

Myomo

Marsi Bionics

LockHeed Martin

Lifeward

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Bionik Laboratories

Alter G

Lower Limb Exoskeleton Rehabilitation Segment by Type

For Adults

For Children

Lower Limb Exoskeleton Rehabilitation Segment by Application

Rehabilitation Center

Family

Other

Lower Limb Exoskeleton Rehabilitation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Limb Exoskeleton Rehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Limb Exoskeleton Rehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Limb Exoskeleton Rehabilitation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lower Limb Exoskeleton Rehabilitation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lower Limb Exoskeleton Rehabilitation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lower Limb Exoskeleton Rehabilitation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lower Limb Exoskeleton Rehabilitation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lower Limb Exoskeleton Rehabilitation Industry Trends Table 2. Lower Limb Exoskeleton Rehabilitation Industry Drivers Table 3. Lower Limb Exoskeleton Rehabilitation Industry Opportunities and Challenges Table 4. Lower Limb Exoskeleton Rehabilitation Industry Restraints Table 5. Global Lower Limb Exoskeleton Rehabilitation Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lower Limb Exoskeleton Rehabilitation Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Manufacturers Table 9. Global Lower Limb Exoskeleton Rehabilitation Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lower Limb Exoskeleton Rehabilitation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lower Limb Exoskeleton Rehabilitation Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lower Limb Exoskeleton Rehabilitation Manufacturers, Product Type & Application Table 13. Global Lower Limb Exoskeleton Rehabilitation Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lower Limb Exoskeleton Rehabilitation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of For Adults Table 17. Major Manufacturers of For Children Table 18. Global Lower Limb Exoskeleton Rehabilitation Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021-2026) & (K Units) Table 20. Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2027-2032) & (K Units) Table 21. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2021-2026) Table 22. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2027-2032) Table 23. Global Lower Limb Exoskeleton Rehabilitation Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2021-2026) & (K Units) Table 25. Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2027-2032) & (K Units) Table 26. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2021-2026) Table 27. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Rehabilitation Center Table 29. Major Manufacturers of Family Table 30. Major Manufacturers of Other Table 31. Global Lower Limb Exoskeleton Rehabilitation Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021-2026) & (K Units) Table 33. Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2027-2032) & (K Units) Table 34. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2021-2026) Table 35. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2027-2032) Table 36. Global Lower Limb Exoskeleton Rehabilitation Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2021-2026) & (K Units) Table 38. Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2027-2032) & (K Units) Table 39. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2021-2026) Table 40. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2027-2032) Table 41. Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2021-2026) & (K Units) Table 43. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Region (2021-2026) Table 44. Global Lower Limb Exoskeleton Rehabilitation Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Lower Limb Exoskeleton Rehabilitation Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 48. North America Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 49. Europe Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 51. Europe Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 58. Global Lower Limb Exoskeleton Rehabilitation Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lower Limb Exoskeleton Rehabilitation Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lower Limb Exoskeleton Rehabilitation Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Region (2021-2026) Table 62. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Region (2027-2032) Table 63. Milebot Company Information Table 64. Milebot Business Overview Table 65. Milebot Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Milebot Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 67. Milebot Recent Development Table 68. Hangzhou Taixi Intelligent Technology Company Information Table 69. Hangzhou Taixi Intelligent Technology Business Overview Table 70. Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 72. Hangzhou Taixi Intelligent Technology Recent Development Table 73. Hangzhou Chengtian Technology Company Information Table 74. Hangzhou Chengtian Technology Business Overview Table 75. Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 77. Hangzhou Chengtian Technology Recent Development Table 78. Parker Hannifin Company Information Table 79. Parker Hannifin Business Overview Table 80. Parker Hannifin Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Parker Hannifin Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 82. Parker Hannifin Recent Development Table 83. Panasonic Company Information Table 84. Panasonic Business Overview Table 85. Panasonic Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Panasonic Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 87. Panasonic Recent Development Table 88. Myomo Company Information Table 89. Myomo Business Overview Table 90. Myomo Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Myomo Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 92. Myomo Recent Development Table 93. Marsi Bionics Company Information Table 94. Marsi Bionics Business Overview Table 95. Marsi Bionics Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Marsi Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 97. Marsi Bionics Recent Development Table 98. LockHeed Martin Company Information Table 99. LockHeed Martin Business Overview Table 100. LockHeed Martin Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. LockHeed Martin Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 102. LockHeed Martin Recent Development Table 103. Lifeward Company Information Table 104. Lifeward Business Overview Table 105. Lifeward Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lifeward Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 107. Lifeward Recent Development Table 108. Hocoma Company Information Table 109. Hocoma Business Overview Table 110. Hocoma Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hocoma Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 112. Hocoma Recent Development Table 113. Ekso Bionics Company Information Table 114. Ekso Bionics Business Overview Table 115. Ekso Bionics Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Ekso Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 117. Ekso Bionics Recent Development Table 118. Cyberdyne Company Information Table 119. Cyberdyne Business Overview Table 120. Cyberdyne Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Cyberdyne Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 122. Cyberdyne Recent Development Table 123. B-TEMIA Inc. Company Information Table 124. B-TEMIA Inc. Business Overview Table 125. B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 127. B-TEMIA Inc. Recent Development Table 128. Bionik Laboratories Company Information Table 129. Bionik Laboratories Business Overview Table 130. Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 132. Bionik Laboratories Recent Development Table 133. Alter G Company Information Table 134. Alter G Business Overview Table 135. Alter G Lower Limb Exoskeleton Rehabilitation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Alter G Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 137. Alter G Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Lower Limb Exoskeleton Rehabilitation Distributors List Table 141. Lower Limb Exoskeleton Rehabilitation Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Lower Limb Exoskeleton Rehabilitation Product Image Figure 2. Global Lower Limb Exoskeleton Rehabilitation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lower Limb Exoskeleton Rehabilitation Market Size (2021-2032) & (US$ Million) Figure 4. Global Lower Limb Exoskeleton Rehabilitation Sales (2021-2032) & (K Units) Figure 5. Global Lower Limb Exoskeleton Rehabilitation Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lower Limb Exoskeleton Rehabilitation Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. For Adults Image Figure 9. For Children Image Figure 10. Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2021-2032) Figure 13. Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2021-2032) Figure 16. Rehabilitation Center Image Figure 17. Family Image Figure 18. Other Image Figure 19. Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2021-2032) Figure 22. Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2021-2032) Figure 25. North America Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 27. U.S. Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 32. Germany Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 39. China Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 47. Brazil Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Lower Limb Exoskeleton Rehabilitation Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Lower Limb Exoskeleton Rehabilitation Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032) & (US$ Million) Figure 58. North America Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lower Limb Exoskeleton Rehabilitation Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lower Limb Exoskeleton Rehabilitation Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • For Adults
  • For Children
Applications
  • Rehabilitation Center
  • Family
  • Other
Companies covered
  • Milebot
  • Hangzhou Taixi Intelligent Technology
  • Hangzhou Chengtian Technology
  • Parker Hannifin
  • Panasonic
  • Myomo
  • Marsi Bionics
  • LockHeed Martin
  • Lifeward
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Bionik Laboratories
  • Alter G

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lower Limb Exoskeleton Rehabilitation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lower Limb Exoskeleton Rehabilitation Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lower Limb Exoskeleton Rehabilitation Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lower Limb Exoskeleton Rehabilitation Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lower Limb Exoskeleton Rehabilitation Market Dynamics
  1. 2.1 Lower Limb Exoskeleton Rehabilitation Industry Trends
  2. 2.2 Lower Limb Exoskeleton Rehabilitation Industry Drivers
  3. 2.3 Lower Limb Exoskeleton Rehabilitation Industry Opportunities and Challenges
  4. 2.4 Lower Limb Exoskeleton Rehabilitation Industry Restraints
3 Lower Limb Exoskeleton Rehabilitation Market by Manufacturers
  1. 3.1 Global Lower Limb Exoskeleton Rehabilitation Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lower Limb Exoskeleton Rehabilitation Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lower Limb Exoskeleton Rehabilitation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lower Limb Exoskeleton Rehabilitation Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lower Limb Exoskeleton Rehabilitation Manufacturers, Product Type & Application
  7. 3.7 Global Lower Limb Exoskeleton Rehabilitation Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lower Limb Exoskeleton Rehabilitation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lower Limb Exoskeleton Rehabilitation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lower Limb Exoskeleton Rehabilitation Tier 1, Tier 2, and Tier 3
4 Lower Limb Exoskeleton Rehabilitation Market by Type
  1. 4.1 Lower Limb Exoskeleton Rehabilitation Type Introduction
  2. 4.1.1 For Adults
  3. 4.1.2 For Children
  4. 4.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Type
  5. 4.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021-2032)
  7. 4.2.3 Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lower Limb Exoskeleton Rehabilitation Revenue by Type
  9. 4.3.1 Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2021-2032)
  11. 4.3.3 Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2021-2032)
5 Lower Limb Exoskeleton Rehabilitation Market by Application
  1. 5.1 Lower Limb Exoskeleton Rehabilitation Application Introduction
  2. 5.1.1 Rehabilitation Center
  3. 5.1.2 Family
  4. 5.1.3 Other
  5. 5.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Application
  6. 5.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021-2032)
  8. 5.2.3 Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lower Limb Exoskeleton Rehabilitation Revenue by Application
  10. 5.3.1 Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2021-2032)
  12. 5.3.3 Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2021-2032)
6 Global Lower Limb Exoskeleton Rehabilitation Sales by Region
  1. 6.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2021-2032)
  3. 6.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2021-2026)
  4. 6.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region
  1. 7.1 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region
  2. 7.1.1 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region (2021-2026)
  4. 7.1.3 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region (2027-2032)
  5. 7.1.4 Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032)
  8. 7.2.2 North America Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032)
  11. 7.3.2 Europe Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Milebot
  2. 8.1.1 Milebot Company Information
  3. 8.1.2 Milebot Business Overview
  4. 8.1.3 Milebot Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Milebot Lower Limb Exoskeleton Rehabilitation Product Portfolio
  6. 8.1.5 Milebot Recent Developments
  7. 8.2 Hangzhou Taixi Intelligent Technology
  8. 8.2.1 Hangzhou Taixi Intelligent Technology Company Information
  9. 8.2.2 Hangzhou Taixi Intelligent Technology Business Overview
  10. 8.2.3 Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio
  12. 8.2.5 Hangzhou Taixi Intelligent Technology Recent Developments
  13. 8.3 Hangzhou Chengtian Technology
  14. 8.3.1 Hangzhou Chengtian Technology Company Information
  15. 8.3.2 Hangzhou Chengtian Technology Business Overview
  16. 8.3.3 Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio
  18. 8.3.5 Hangzhou Chengtian Technology Recent Developments
  19. 8.4 Parker Hannifin
  20. 8.4.1 Parker Hannifin Company Information
  21. 8.4.2 Parker Hannifin Business Overview
  22. 8.4.3 Parker Hannifin Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Parker Hannifin Lower Limb Exoskeleton Rehabilitation Product Portfolio
  24. 8.4.5 Parker Hannifin Recent Developments
  25. 8.5 Panasonic
  26. 8.5.1 Panasonic Company Information
  27. 8.5.2 Panasonic Business Overview
  28. 8.5.3 Panasonic Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Panasonic Lower Limb Exoskeleton Rehabilitation Product Portfolio
  30. 8.5.5 Panasonic Recent Developments
  31. 8.6 Myomo
  32. 8.6.1 Myomo Company Information
  33. 8.6.2 Myomo Business Overview
  34. 8.6.3 Myomo Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Myomo Lower Limb Exoskeleton Rehabilitation Product Portfolio
  36. 8.6.5 Myomo Recent Developments
  37. 8.7 Marsi Bionics
  38. 8.7.1 Marsi Bionics Company Information
  39. 8.7.2 Marsi Bionics Business Overview
  40. 8.7.3 Marsi Bionics Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Marsi Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio
  42. 8.7.5 Marsi Bionics Recent Developments
  43. 8.8 LockHeed Martin
  44. 8.8.1 LockHeed Martin Company Information
  45. 8.8.2 LockHeed Martin Business Overview
  46. 8.8.3 LockHeed Martin Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LockHeed Martin Lower Limb Exoskeleton Rehabilitation Product Portfolio
  48. 8.8.5 LockHeed Martin Recent Developments
  49. 8.9 Lifeward
  50. 8.9.1 Lifeward Company Information
  51. 8.9.2 Lifeward Business Overview
  52. 8.9.3 Lifeward Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lifeward Lower Limb Exoskeleton Rehabilitation Product Portfolio
  54. 8.9.5 Lifeward Recent Developments
  55. 8.10 Hocoma
  56. 8.10.1 Hocoma Company Information
  57. 8.10.2 Hocoma Business Overview
  58. 8.10.3 Hocoma Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hocoma Lower Limb Exoskeleton Rehabilitation Product Portfolio
  60. 8.10.5 Hocoma Recent Developments
  61. 8.11 Ekso Bionics
  62. 8.11.1 Ekso Bionics Company Information
  63. 8.11.2 Ekso Bionics Business Overview
  64. 8.11.3 Ekso Bionics Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ekso Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio
  66. 8.11.5 Ekso Bionics Recent Developments
  67. 8.12 Cyberdyne
  68. 8.12.1 Cyberdyne Company Information
  69. 8.12.2 Cyberdyne Business Overview
  70. 8.12.3 Cyberdyne Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cyberdyne Lower Limb Exoskeleton Rehabilitation Product Portfolio
  72. 8.12.5 Cyberdyne Recent Developments
  73. 8.13 B-TEMIA Inc.
  74. 8.13.1 B-TEMIA Inc. Company Information
  75. 8.13.2 B-TEMIA Inc. Business Overview
  76. 8.13.3 B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Product Portfolio
  78. 8.13.5 B-TEMIA Inc. Recent Developments
  79. 8.14 Bionik Laboratories
  80. 8.14.1 Bionik Laboratories Company Information
  81. 8.14.2 Bionik Laboratories Business Overview
  82. 8.14.3 Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Product Portfolio
  84. 8.14.5 Bionik Laboratories Recent Developments
  85. 8.15 Alter G
  86. 8.15.1 Alter G Company Information
  87. 8.15.2 Alter G Business Overview
  88. 8.15.3 Alter G Lower Limb Exoskeleton Rehabilitation Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Alter G Lower Limb Exoskeleton Rehabilitation Product Portfolio
  90. 8.15.5 Alter G Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lower Limb Exoskeleton Rehabilitation Value Chain Analysis
  2. 9.1.1 Lower Limb Exoskeleton Rehabilitation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lower Limb Exoskeleton Rehabilitation Production Mode & Process
  6. 9.2 Lower Limb Exoskeleton Rehabilitation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lower Limb Exoskeleton Rehabilitation Distributors
  9. 9.2.3 Lower Limb Exoskeleton Rehabilitation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst